Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN

Blood (2023) 142 (Supplement 1): 636.

https://doi.org/10.1182/blood-2023-174750

Published: 2023

Journal Articles

ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Blood (2019) 134 (Supplement_1): 31.

https://doi.org/10.1182/blood-2019-128404

Published: 2019

Journal Articles

Real-World Results on Ibrutinib in Relapsed/Refractory CLL: A 21-Month Follow-up of 95 Swedish Patients Treated in a Compassionate Use Program

Maria Winqvist, MSc, MD, Per-Ola Andersson, MD PhD, Anna Asklid, MD, Karin Karlsson, MD, Claes Karlsson, MD PhD, Birgitta Lauri, MD, Jeanette Lundin, MD PhD Assoc Prof, Mattias Mattsson, MD, Stefan Norin, MD PhD, Anna Bergendahl Sandstedt, MD, Lotta Hansson, Anders Österborg, MD PhD Prof.

Blood (2017) 130 (Supplement 1): 5353.

https://doi.org/10.1182/blood.V130.Suppl_1.5353.5353

Published: 2017

Journal Articles

Outcome of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First Line Therapy: A Swedish Nation-Wide Study on 1053 Consecutive Patients Treated between 2007 and 2013

Sandra Eketorp Sylvan, MD PhD, Anna Asklid, MD, Hemming Johansson, Jenny Klintman, MD PhD, Jenny Bjellvi, MD, Staffan Tolvgård, MD, Eva Kimby, Stefan Norin, MD PhD, P-O Andersson, MD PhD Prof., Claes Karlsson, MD PhD, Karin Karlsson, MD, Birgitta Lauri, MD, Mattias Mattsson, MD, Anna Bergendahl Sandstedt, MD, Maria Strandberg, MD, Anders Österborg, MD PhD Prof., Lotta Hansson

Blood (2017) 130 (Supplement 1): 1744.

https://doi.org/10.1182/blood.V130.Suppl_1.1744.1744

Published: 2017

Journal Articles

Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program

Lotta Hansson, MD PhD, Maria Winqvist, MD, Anna Asklid, MD, P-O Andersson, MDPhD, Karin Karlsson, MD, Claes Karlsson, MDPhD, Birgitta Lauri, MD, Jeanette Lundin, MD PhD, Mattias Mattsson, MD, Stefan Norin, MDPhD, Anna Sandstedt, MD, Anders Österborg, MDPhD

Blood (2015) 126 (23): 1745.

https://doi.org/10.1182/blood.V126.23.1745.1745

Published: 2015

Journal Articles

Population-based analyses in adult acute lymphoblastic leukemia

Gunnar Juliusson, Karin Karlsson, Helen Hallböök

Blood (2010) 116 (6): 1011.

https://doi.org/10.1182/blood-2010-03-272724

Published: 2010

Journal Articles

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis

Blood (2008) 111 (3): 1524–1533.

https://doi.org/10.1182/blood-2007-07-099564

Published: 2008

Includes: Supplemental data

Journal Articles

Stereotyped Patterns of Somatic Hypermutation (SHM) in Subsets of Patients with Chronic Lymphocytic Leukemia (CLL): Implications for the Role of Antigen Selection in Leukemogenesis.

Blood (2007) 110 (11): 744.

https://doi.org/10.1182/blood.V110.11.744.744

Published: 2007

Journal Articles

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in V H 3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

Blood (2006) 107 (7): 2889–2894.

https://doi.org/10.1182/blood-2005-06-2227

Published: 2006

Includes: Supplemental data

Journal Articles

Strikingly Homologous Immunoglobulin Gene Rearrangements and Poor Outcome in V H 3-21-Utilizing Chronic Lymphocytic Leukemia Independent of Geographical Origin and Mutational Status.

Fiona Murray, Mia Thorselius, Alexander Krober, Ulf Thunberg, Gerard Tobin, Andreas Buhler, Dirk Kienle, Emilia Albesiano, Lan-Phuong Dao-Ung, James Wiley, Juhani Vilpo, Anna Laurell, Goran Roos, Karin Karlsson, Nicholas Chiorazzi, Roberto Marasca, Hartmut Dohner, Stephan Stilgenbauer, Richard Rosenquist

Blood (2005) 106 (11): 175.

https://doi.org/10.1182/blood.V106.11.175.175

Published: 2005

Journal Articles

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to V H gene mutation status

Pawel Grabowski, Magnus Hultdin, Karin Karlsson, Gerard Tobin, Anna Åleskog, Ulf Thunberg, Anna Laurell, Christer Sundström, Richard Rosenquist, Göran Roos

Blood (2005) 105 (12): 4807–4812.

https://doi.org/10.1182/blood-2004-11-4394

Published: 2005

Journal Articles

Telomere Length as a Prognostic Parameter in Chronic Lymphocytic Leukemia with Reference to IGV(H) Gene Mutation Status.

Goran Roos, Pawel Grabowski, Magnus Hultdin, Karin Karlsson, Ulf Thunberg, Gerard Tobin, Anna Laurell, Richard Rosenquist

Blood (2004) 104 (11): 4795.

https://doi.org/10.1182/blood.V104.11.4795.4795

Published: 2004

Journal Articles

The Expression of mRNA and Enzyme Activity of Deoxycytidine- and Deoxyguanosine Kinases in Cell from Patients with Untreated B-Cell Chronic Lymphocytic Leukemia.

Kourosh Lotfi, MD, PhD, Karin Karlsson, MD, Gunnar Juliusson, MD, PhD, Curt Petersona, MD, PhD, Staffan Eriksson, PhD, Freidoun Albertioni, PhD

Blood (2004) 104 (11): 4378.

https://doi.org/10.1182/blood.V104.11.4378.4378

Published: 2004

Journal Articles

Cladribine (CdA) or Fludarabine (F) or High-Dose Intermittent Chlorambucil (Chl) as First-Line Treatment of Symptomatic Chronic Lymphocytic Leukemia? First Interim Analysis of Data from the International Randomized Phase III Trial.

Karin Karlsson, Mats Strömberg, Viggo Jönsson, Devinder Gill, Jens Hammerström, Jonas Wallvik, Stephen Mulligan, Kenneth Bradstock, Jan Liliemark, Gunnar Juliusson

Blood (2004) 104 (11): 3470.

https://doi.org/10.1182/blood.V104.11.3470.3470

Published: 2004

Journal Articles

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Gerard Tobin, Ulf Thunberg, Karin Karlsson, Fiona Murray, Anna Laurell, Kerstin Willander, Gunilla Enblad, Mats Merup, Juhani Vilpo, Gunnar Juliusson, Christer Sundström, Ola Söderberg, Göran Roos, Richard Rosenquist

Blood (2004) 104 (9): 2879–2885.

https://doi.org/10.1182/blood-2004-01-0132

Published: 2004

Journal Articles

Chronic lymphocytic leukemias utilizing the V H 3-21 gene display highly restricted V λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

Gerard Tobin, Ulf Thunberg, Anna Johnson, Inger Eriksson, Ola Söderberg, Karin Karlsson, Mats Merup, Gunnar Juliusson, Juhani Vilpo, Gunilla Enblad, Christer Sundström, Göran Roos, Richard Rosenquist

Blood (2003) 101 (12): 4952–4957.

https://doi.org/10.1182/blood-2002-11-3485

Published: 2003

NARROW

Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN

ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Real-World Results on Ibrutinib in Relapsed/Refractory CLL: A 21-Month Follow-up of 95 Swedish Patients Treated in a Compassionate Use Program

Outcome of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First Line Therapy: A Swedish Nation-Wide Study on 1053 Consecutive Patients Treated between 2007 and 2013

Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program

Population-based analyses in adult acute lymphoblastic leukemia

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis

Stereotyped Patterns of Somatic Hypermutation (SHM) in Subsets of Patients with Chronic Lymphocytic Leukemia (CLL): Implications for the Role of Antigen Selection in Leukemogenesis.

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in V H 3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

Strikingly Homologous Immunoglobulin Gene Rearrangements and Poor Outcome in V H 3-21-Utilizing Chronic Lymphocytic Leukemia Independent of Geographical Origin and Mutational Status.

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to V H gene mutation status

Telomere Length as a Prognostic Parameter in Chronic Lymphocytic Leukemia with Reference to IGV(H) Gene Mutation Status.

The Expression of mRNA and Enzyme Activity of Deoxycytidine- and Deoxyguanosine Kinases in Cell from Patients with Untreated B-Cell Chronic Lymphocytic Leukemia.

Cladribine (CdA) or Fludarabine (F) or High-Dose Intermittent Chlorambucil (Chl) as First-Line Treatment of Symptomatic Chronic Lymphocytic Leukemia? First Interim Analysis of Data from the International Randomized Phase III Trial.

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia

Chronic lymphocytic leukemias utilizing the V H 3-21 gene display highly restricted V λ 2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only